Foghorn Therapeutics's total assets for Q3 2024 were $308.37M, a decrease of -6.15% from the previous quarter. FHTX total liabilities were $336.66M for the fiscal quarter, a -1.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.